Health-care companies ticked down as deal activity offset fears about generic competition for one key category of drugs.

Health-care companies ticked down as deal activity offset fears about generic competition for one key category of drugs.

Health-care companies rose as deal activity in the sector intensified.

Health-care companies fell, but not by much, as traders continued rotating out of tech into lagging sectors.